Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases.

New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases. Nat Clin Pract Rheumatol. 2007 Oct; 3(10):570-9; quiz 1 p following 589.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.